Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
et al., Diabetes/Metabolism Research and Reviews 2
BPC-157 Research Applications BPC-157 is investigated in in-vitro and animal models of angiogenesis and endothelial tube formation, tendon and ligament repair, gastrointestinal mucosal integrity and experimental colitis, nitric oxide pathway modulation, and cytoprotection across musculoskeletal, neural and digestive tissue
Active Ingredient Semaglutide (1.34 mg/mL) Dose Strength per Click 0.5 mg per single weekly injection Total Content per Pen 2 mg Semaglutide in 1.5 mL solution Primary Manufacturer Alkem Laboratories Ltd Therapeutic Class GLP-1 Receptor Agonist (Anti-Obesity / Antidiabetic) Administration Route Subcutaneous Injection (Weekly baseline) Kit Accessories 1 Pre-filled Pen, 4 Sterile Needles, 4 Alcohol Swabs
In a single-blind parallel-design clinical trial, Atan et al
US$ 20.54
US$ 23.76
US$ 21.73
